XML 56 R33.htm IDEA: XBRL DOCUMENT v3.6.0.2
Quarterly Financial Data (unaudited) (Tables)
12 Months Ended
Dec. 31, 2016
Quarterly Financial Data (unaudited)  
Schedule of quarterly financial information

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Year ended December 31, 2016

 

 

 

(In thousands, except per share data)

 

 

    

First Quarter

    

Second Quarter

    

Third Quarter

    

Fourth Quarter

 

Revenue:

 

 

 

 

 

 

 

 

 

 

 

 

 

Product revenue

 

$

437

 

$

151

 

$

580

 

$

579

 

Research revenue

 

 

659

 

 

839

 

 

504

 

 

331

 

Total revenue

 

$

1,096

 

$

990

 

$

1,084

 

$

910

 

Costs and expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of product revenue

 

 

1,026

 

 

1,781

 

 

1,894

 

 

2,171

 

Research and development

 

 

6,589

 

 

6,369

 

 

5,200

 

 

5,851

 

Selling, general and administrative

 

 

6,204

 

 

6,143

 

 

5,935

 

 

5,795

 

Total costs and expenses

 

 

13,819

 

 

14,293

 

 

13,029

 

 

13,817

 

Loss from operations

 

$

(12,723)

 

$

(13,303)

 

$

(11,945)

 

$

(12,907)

 

Net loss

 

$

(13,426)

 

$

(14,046)

 

$

(12,783)

 

$

(14,549)

 

Net loss applicable to common shareholders

 

$

(13,426)

 

$

(14,046)

 

$

(12,783)

 

$

(14,549)

 

Per share data:

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss per common share—basic and diluted

 

$

(0.55)

 

$

(0.58)

 

$

(0.51)

 

$

(0.48)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Year ended December 31, 2015

 

 

 

(In thousands, except per share data)

 

 

    

First Quarter

    

Second Quarter

    

Third Quarter

    

Fourth Quarter

 

Revenue:

 

 

 

 

 

 

 

 

 

 

 

 

 

Product revenue

 

$

11

 

$

 

$

245

 

$

343

 

Research revenue

 

 

178

 

 

564

 

 

804

 

 

668

 

Total revenue

 

$

189

 

$

564

 

$

1,049

 

$

1,011

 

Costs and expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of product revenue

 

 

1

 

 

 —

 

 

829

 

 

910

 

Research and development

 

 

5,869

 

 

6,651

 

 

6,204

 

 

6,638

 

Selling, general and administrative

 

 

4,468

 

 

4,437

 

 

5,181

 

 

5,008

 

Total costs and expenses

 

 

10,338

 

 

11,088

 

 

12,214

 

 

12,556

 

Loss from operations

 

$

(10,149)

 

$

(10,524)

 

$

(11,165)

 

$

(11,545)

 

Net loss

 

$

(10,619)

 

$

(10,995)

 

$

(11,644)

 

$

(12,032)

 

Net loss applicable to common shareholders

 

$

(10,619)

 

$

(10,995)

 

$

(11,644)

 

$

(12,032)

 

Per share data:

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss per common share—basic and diluted

 

$

(0.53)

 

$

(0.54)

 

$

(0.57)

 

$

(0.56)